Correlation Between Novartis and Bristol Myers
Can any of the company-specific risk be diversified away by investing in both Novartis and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Bristol Myers Squibb, you can compare the effects of market volatilities on Novartis and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Bristol Myers.
Diversification Opportunities for Novartis and Bristol Myers
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Novartis and Bristol is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Novartis i.e., Novartis and Bristol Myers go up and down completely randomly.
Pair Corralation between Novartis and Bristol Myers
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.84 times more return on investment than Bristol Myers. However, Novartis AG ADR is 1.19 times less risky than Bristol Myers. It trades about -0.07 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.17 per unit of risk. If you would invest 9,605 in Novartis AG ADR on January 20, 2024 and sell it today you would lose (169.00) from holding Novartis AG ADR or give up 1.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Novartis AG ADR vs. Bristol Myers Squibb
Performance |
Timeline |
Novartis AG ADR |
Bristol Myers Squibb |
Novartis and Bristol Myers Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novartis and Bristol Myers
The main advantage of trading using opposite Novartis and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.Novartis vs. Alkermes Plc | Novartis vs. Ironwood Pharmaceuticals | Novartis vs. Deciphera Pharmaceuticals LLC | Novartis vs. Eagle Pharmaceuticals |
Bristol Myers vs. Alkermes Plc | Bristol Myers vs. Ironwood Pharmaceuticals | Bristol Myers vs. Deciphera Pharmaceuticals LLC | Bristol Myers vs. Eagle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |